The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19.
The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19. Acta Med Indones. 2020 Apr;52(2):163-171 Authors: Rinaldi I, Muthalib A, Astowo P, Irawan B, Susanto N, Magdalena L, Maha IHRT, Wicaksono S Abstract Global widespread of current coronavirus disease 2019 (COVID-19) pandemic has emerged huge predicament to healthcare systems globally. This disease caused by a new beta-type coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), may lead to systemic multiorgan dysfunction syndrome and subsequently cause death due to abundant angiotensin converting enzyme 2 as its functional receptors throughout body. Oncology patients even have a worse prognosis with greater infection susceptibility because they are in a state of suppression of the systemic immune system due to malignancy and anticancer therapy. This problem makes adequate and appropriate treatment urgently needed. Through randomized clinical trials, various drugs were known to have good responses in COVID-19 patients. Here, we reported a-49-year-old-woman that was confirmed for COVID-19 by clinical manifestation, radiology profile, high procalcitonin concentration, and positive polymerase chain reaction (PCR) test. The patient also had breast and thyroid cancers history and had undergone various therapeutic modalities such as chemotherapy, thyroid surgery, and breast surgery. She was undergoing hormone...
Publication date: Available online 28 September 2020Source: European Journal of RadiologyAuthor(s): U. Hueck, H. Muggenthaler, M. Hubig, A. Heinrich, F. Güttler, R. Wagner, G. Mall, U. Teichgräber
Publication date: Available online 28 September 2020Source: European Journal of RadiologyAuthor(s): Michelle I. Higgins, Dylan J. Martini, Dattatraya H. Patil, Sean Steele, Sean Evans, Benjamin P. Petrinec, Sarah P. Psutka, Aarti Sekhar, Mehmet Asim Bilen, Viraj A. Master
Publication date: Available online 28 September 2020Source: European Journal of RadiologyAuthor(s): Anne Nielsen Moody, Karina Cox, Isobel Haigh, Yan Chen, Nisha Sharma
ConclusionCRC-OMD treatment represents a relevant part of the everyday clinical practice of the IR Italian centers with promising future prospects. Heterogeneity persists in clinical indications, requiring more robust evidence to set indications and to diffuse clinical applications.
Publication date: Available online 29 September 2020Source: Academic RadiologyAuthor(s): Lei Zhang, Zhimin Ye, Lei Ruan, Mingxiang Jiang
Publication date: Available online 28 September 2020Source: Social Science &MedicineAuthor(s): Gareth. Wiltshire, Emma. Pullen, Frankie.F. Brown, Mike. Osborn, Sarah. Wexler, Mark. Beresford, Mark. Tooley, James.E. Turner
Publication date: 1 January 2021Source: Personality and Individual Differences, Volume 168Author(s): Marta Bodecka, Iwona Nowakowska, Anna Zajenkowska, Joanna Rajchert, Izabela Kaźmierczak, Irena Jelonkiewicz
Publication date: Available online 28 September 2020Source: Pathology - Research and PracticeAuthor(s): Lei Chen, Xuehui Wang, Changle Ji, Jiashu Hu, Lin Fang
Instead of adjuvant radiotherapy after prostatectomy, observation and early salvage radiotherapy offer equal outcomes with fewer side effects.Medscape Medical News
Conclusion: Nanocomposites proved superior carriers to solid dispersions in terms of the dissolution enhancement. Further, in vivo studies indicated that the induction of systolic and diastolic blood pressure in the optimized formulation (NC1) was significantly decreased in comparison to the disease control group (P
More News: Avelox | Breast Cancer | Breast Surgery | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Coronavirus | COVID-19 | CT Scan | Hormonal Therapy | Hormones | Internal Medicine | Moxifloxacin | Pandemics | PET Scan | Radiography | Radiology | Respiratory Medicine | SARS | Thyroid | Thyroid Cancer